# Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

> **NCT01843868** · NA · WITHDRAWN · sponsor: **Australasian Leukaemia and Lymphoma Group**

## Conditions studied

- Lymphoma, Non-Hodgkin

## Interventions

- **DRUG:** Standard anti-emetics in conjunction with R-CHOP

## Key facts

- **NCT ID:** NCT01843868
- **Lead sponsor:** Australasian Leukaemia and Lymphoma Group
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study halted prematurely, prior to enrollment of first participant due to protracted logistical and subsequent funding matters.
- **Last updated:** 2024-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01843868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01843868, "Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01843868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*